Form 4: Hubbell Inc. CEO Gerben Bakker Reports Stock Transactions
SEC Form 4 Filing
Hubbell Inc.'s Chairman, President, and CEO, Gerben Bakker, reported the exercise of stock appreciation rights and subsequent sale of common stock on August 9, 2024.
Summary
- On August 9, 2024, Gerben Bakker, Chairman, President, and CEO of Hubbell Inc., executed transactions involving the company's stock.
- Bakker exercised stock appreciation rights (SARs) converting them into 13,765 and 33,169 shares of common stock at exercise prices of $129.28 and $149.49 respectively.
- Following the exercise of SARs, Bakker disposed of 31,257 shares to cover withholding taxes at a price of $373.63.
- Bakker also sold a total of 15,677 shares of common stock in multiple transactions at weighted average prices ranging from $372.74 to $376.84.
- After these transactions, Bakker directly owns 66,415 shares of Hubbell Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions. The sentiment is neither positive nor negative as it simply reflects the CEO's exercise of stock options and subsequent sale of shares.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options and stock appreciation rights to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of the SARs appear to be within typical ranges for executive compensation plans.
- Similar filings are made by executives at comparable companies like Eaton Corporation and Siemens when they exercise options or sell shares.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of shares held by the CEO.
- The impact on employees, customers, suppliers, and creditors is likely to be negligible.
Key Dates
| Date | Description |
|---|---|
| 07/01/2020 | Date when the first tranche of the stock appreciation right (SAR) with an exercise price of $129.28 vested and became exercisable. |
| 02/13/2021 | Date when the first tranche of the stock appreciation right (SAR) with an exercise price of $149.49 vested and became exercisable. |
| 08/09/2024 | Date of the reported transactions, including exercise of stock appreciation rights and sale of common stock. |
| 08/13/2024 | Date of the signature on the Form 4 filing. |
| 07/01/2029 | Expiration date of the Stock Appreciation Right with an exercise price of $129.28. |
| 02/13/2030 | Expiration date of the Stock Appreciation Right with an exercise price of $149.49. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.